Celldex Therapeutics (CLDX) Return on Equity [ROE] (2009 - 2026)
Celldex Therapeutics' Return on Equity [ROE] was -51.34% in Q2 2026, down 21.95 percentage points from -29.39% a year earlier but up 6.35 percentage points from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Celldex Therapeutics came in at -40.62%, down 13.77 percentage points from FY2024.
- Return on Equity [ROE] shows a five-year change of -1.21 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -26.84% in FY2024 (+10.60 pp), -37.45% in FY2023 (-7.32 pp), -30.13% in FY2022 (-7.70 pp) and -22.43% in FY2021 (+16.98 pp).
- Quarterly Return on Equity [ROE] has moved between -57.69% (Q1 2026) and -16.47% (Q4 2021) over five years.
- Compared with a year earlier, Return on Equity [ROE] has declined for six straight quarters, with an average year-over-year change of -7.55 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2024 (a gain of 28.27 percentage points); the worst was Q1 2026 (a drop of 33.02 percentage points).
- Per Business Quant data, CLDX's Return on Equity [ROE] in the three quarters before Q2 2026 was -57.69% (Q1 2026), -45.98% (Q4 2025) and -35.82% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Celldex Therapeutics | 2.41 Bn | 69.14 Mn | - | -45.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -45.92% |
| Jun 30, 2026 | -51.69% |
| Mar 31, 2026 | -57.90% |
| Dec 31, 2025 | -45.92% |
| Sep 30, 2025 | -36.06% |
| Jun 30, 2025 | -29.16% |
| Mar 31, 2025 | -24.49% |
| Dec 31, 2024 | -20.60% |
| Sep 30, 2024 | -18.87% |
| Jun 30, 2024 | -18.22% |
| Mar 31, 2024 | -22.84% |
| Dec 31, 2023 | -41.24% |
| Sep 30, 2023 | -46.68% |
| Jun 30, 2023 | -38.14% |
| Mar 31, 2023 | -37.09% |
| Dec 31, 2022 | -33.64% |
| Sep 30, 2022 | -30.58% |
| Jun 30, 2022 | -26.90% |
| Mar 31, 2022 | -19.45% |
| Dec 31, 2021 | -16.63% |
API Access
Celldex Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();